[ARS] NanoVibronix, Inc. SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

11/10/2025 - 06:07 AM

ARS - NanoVibronix, Inc.

ARS Filing - NanoVibronix, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: NanoVibronix, Inc. (NAOV)

Acceptance Date: 2025-11-10T06:07:41.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Nanovibronix Inc

NASDAQ:NAOV

NAOV Rankings

#6638 Ranked by Market Cap

N/A Ranked by Dividends

NAOV Latest News

Sep 18, 2025

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Sep 16, 2025

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 15, 2025

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio

Sep 4, 2025

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Aug 8, 2025

NanoVibronix Announces Reverse Stock Split

NAOV Latest SEC Filings

Nov 10, 2025

[DEF 14A] NanoVibronix, Inc. Definitive Proxy Statement

Oct 30, 2025

[PRE 14A] NanoVibronix, Inc. Preliminary Proxy Statement

Oct 30, 2025

[8-K] NanoVibronix, Inc. Reports Material Event

Oct 6, 2025

[S-3/A] NanoVibronix, Inc. Amended Shelf Registration Statement

Sep 17, 2025

[8-K] NanoVibronix, Inc. Reports Material Event

NAOV Stock Data

Market Cap 4.09M

Float 1.00M

Insiders Ownership 1.04%

Institutions Ownership 0.75%

Short Percent 1.91%

Industry Medical Devices

Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies

Website Link

Country United States

City TYLER